Abstract PS1-08-12: Rewiring Treatment Pathways: How Molecular Profiling After CDK4/6 Inhibitor (CDK4/6i) Failure Shapes Future Therapy in Luminal HER2-Negative Breast Cancer
Year: 2026
Type: conference-abstract
Source: Clinical Cancer Research
Institution: AC Camargo Hospital
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7129604588
Cites:
Cited by:
Related to:
